| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000230499.1 |
Afatinib |
Breast invasive carcinoma |
0.028211414 |
Resistant |
| ENSG00000230499.1 |
Afatinib |
Colon adenocarcinoma |
0.035673767 |
Resistant |
| ENSG00000230499.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.032889927 |
Resistant |
